Book

Description

Cancer is no longer understood as a disease driven by isolated genetic mutations, but as a dynamic and adaptive biological system shaped by genomic instability, transcriptional reprogramming, proteomic signaling networks, metabolic rewiring, and microenvironmental interactions. Multi-Omics Integration in Cancer Therapeutics explores how the convergence of genomics, transcriptomics, proteomics, metabolomics, and epigenomics is transforming the landscape of oncology research and clinical care. This book provides a comprehensive framework for understanding how diverse molecular layers can be integrated to uncover causal disease mechanisms, identify actionable targets, and overcome therapeutic resistance. It highlights cutting-edge technologies including high-throughput sequencing, single-cell profiling, spatial transcriptomics, and artificial intelligence-driven analytics. Emphasis is placed on network biology approaches that reconstruct signaling circuits and predict drug responses within heterogeneous tumor ecosystems. Bridging molecular discovery with clinical translation, the text discusses biomarker development, molecular tumor boards, precision drug design, and systems-level strategies for personalized therapy. Through a synthesis of experimental evidence, computational modeling, and translational insights, this volume equips researchers, clinicians, and pharmaceutical scientists with the tools needed to harness integrative multi-omics for next-generation cancer therapeutics. Designed for advanced students, oncology researchers, and professionals in pharmaceutical and biomedical sciences, this book presents a forward-looking vision of precision oncology where data integration drives durable and individualized cancer treatment strategies.